KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crocs (CROX) Total Debt (2016 - 2025)

Crocs has reported Total Debt over the past 16 years, most recently at $1.2 billion for Q4 2025.

  • Quarterly results put Total Debt at $1.2 billion for Q4 2025, down 8.78% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (down 8.78% YoY), and the annual figure for FY2025 was $1.2 billion, down 8.78%.
  • Total Debt for Q4 2025 was $1.2 billion at Crocs, down from $1.3 billion in the prior quarter.
  • Over the last five years, Total Debt for CROX hit a ceiling of $2.9 billion in Q1 2022 and a floor of $341.1 million in Q1 2021.
  • Median Total Debt over the past 5 years was $1.5 billion (2024), compared with a mean of $1.6 billion.
  • Biggest five-year swings in Total Debt: skyrocketed 743.27% in 2022 and later decreased 28.34% in 2023.
  • Crocs' Total Debt stood at $771.4 million in 2021, then skyrocketed by 201.07% to $2.3 billion in 2022, then decreased by 28.34% to $1.7 billion in 2023, then decreased by 18.93% to $1.3 billion in 2024, then dropped by 8.78% to $1.2 billion in 2025.
  • The last three reported values for Total Debt were $1.2 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.